Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2009 (2009), Article ID 738038, 8 pages
http://dx.doi.org/10.1155/2009/738038
Research Article

Influence of Epinastine Hydrochloride, an H 1 -Receptor Antagonist, on the Function of Mite Allergen-Pulsed Murine Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

1Department of Otolaryngology, School of Medicine, Showa University, Tokyo 142-8555, Japan
2Division of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama 226-8555, Japan

Received 19 August 2008; Revised 14 November 2008; Accepted 16 January 2009

Academic Editor: Tania Silvia Fröde

Copyright © 2009 Ken-Zaburo Oshima et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Howarth, M. Salagean, and D. Dokic, “Allergic rhinitis: not purely a histamine-related disease,” Allergy, vol. 55, pp. 7–16, 2000. View at Publisher · View at Google Scholar
  2. R. E. Jonkers and J. S. van der Zee, “Anti-IgE and other new immunomodulation-based therapies for allergic asthma,” The Netherlands Journal of Medicine, vol. 63, no. 4, pp. 121–128, 2005. View at Google Scholar
  3. M. M. Abdelaziz, J. L. Devalia, O. A. Khair, H. Bayram, A. J. Prior, and R. J. Davies, “Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cells of patients with seasonal allergic rhinitis,” Journal of Allergy and Clinical Immunology, vol. 101, no. 3, pp. 410–420, 1998. View at Publisher · View at Google Scholar
  4. U. Pipkorn, “Mediators and nasal allergy,” Clinical & Experimental Allergy, vol. 19, no. 6, pp. 585–589, 1989. View at Publisher · View at Google Scholar
  5. F. W. Fraunfelder, “Epinastine hydrochloride for atopic disease,” Drugs of Today, vol. 40, no. 8, pp. 677–683, 2004. View at Publisher · View at Google Scholar
  6. K. Tasaka, M. Mio, and M. Okamoto, “Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs,” Annals of Allergy, vol. 56, no. 6, pp. 464–469, 1986. View at Google Scholar
  7. K. Asano, A. Furuta, K.-I. Kanai, S. Sakaue, H. Suzaki, and T. Hisamitsu, “Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro,” Mediators of Inflammation, vol. 2008, Article ID 265095, 8 pages, 2008. View at Publisher · View at Google Scholar · View at PubMed
  8. K. Asano, K.-I. Kanai, and H. Suzaki, “Suppressive activity of fexofenadine hydrochloride on thymus- and activation-regulated chemokine production from human peripheral blood leukocytes in response to antigenic stimulation in vitro,” International Archives of Allergy and Immunology, vol. 133, no. 3, pp. 267–275, 2004. View at Publisher · View at Google Scholar · View at PubMed
  9. K.-I. Kanai, K. Asano, S. Watanabe, Y. Kyo, and H. Suzaki, “Epinastine hydrochloride antagonism against interleukin-4-mediated T cell cytokine imbalance in vitro,” International Archives of Allergy and Immunology, vol. 140, no. 1, pp. 43–52, 2006. View at Publisher · View at Google Scholar · View at PubMed
  10. K. Asano, K.-I. Kanai, and H. Suzaki, “Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro,” Clinical & Experimental Allergy, vol. 34, no. 12, pp. 1890–1898, 2004. View at Publisher · View at Google Scholar · View at PubMed
  11. K. Asano, K.-I. Kanai, A. Furuta, A. Furuya, H. Suzaki, and T. Hisamitsu, “Suppressive activity of fexofenadine hydrochloride on nitric oxide production in-vitro and in-vivo,” Journal of Pharmacy and Pharmacology, vol. 59, no. 10, pp. 1389–1395, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. D. Weissman, Y. Li, J. M. Orenstein, and A. S. Fauci, “Both a precursor and a mature population of dendritic cells can bind HIV: however, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells,” The Journal of Immunology, vol. 155, no. 8, pp. 4111–4117, 1995. View at Google Scholar
  13. S. Saeki, H. Matsuse, Y. Kondo et al., “Effects of antiasthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients,” Journal of Allergy and Clinical Immunology, vol. 114, no. 3, pp. 538–544, 2004. View at Publisher · View at Google Scholar · View at PubMed
  14. A. Tanaka, K. Minoguchi, K. T. R. Samson et al., “Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma,” Clinical & Experimental Allergy, vol. 37, no. 7, pp. 1083–1089, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. I. Machida, H. Matsuse, Y. Kondo et al., “Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma,” The Journal of Immunology, vol. 172, no. 3, pp. 1833–1838, 2004. View at Google Scholar
  16. I. Machida, H. Matsuse, Y. Kondo et al., “Effects of various anti-asthmatic agents on mite allergen-pulsed murine bone marrow-derived dendritic cells,” Clinical & Experimental Allergy, vol. 35, no. 7, pp. 884–888, 2005. View at Publisher · View at Google Scholar · View at PubMed
  17. M. B. Lutz, N. Kukutsch, A. L. J. Ogilvie et al., “An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow,” Journal of Immunological Methods, vol. 223, no. 1, pp. 77–92, 1999. View at Publisher · View at Google Scholar
  18. G. Gudmundsson and G. W. Hunninghake, “Interferon-γ is necessary for the expression of hypersensitivity pneumonitis,” The Journal of Clinical Investigation, vol. 99, no. 10, pp. 2386–2390, 1997. View at Publisher · View at Google Scholar · View at PubMed
  19. I. Bellinghausen, U. Brand, J. Knop, and J. Saloga, “Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors,” Journal of Allergy and Clinical Immunology, vol. 105, no. 5, pp. 988–996, 2000. View at Publisher · View at Google Scholar · View at PubMed
  20. I. Meyts, P. W. Hellings, G. Hens et al., “IL-12 contributes to allergen-induced airway inflammation in experimental asthma,” The Journal of Immunology, vol. 177, no. 9, pp. 6460–6470, 2006. View at Google Scholar
  21. R. Manetti, P. Parronchi, M. G. Giudizi et al., “Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells,” Journal of Experimental Medicine, vol. 177, no. 4, pp. 1199–1204, 1993. View at Publisher · View at Google Scholar
  22. M. Kiniwa, M. Gately, U. Gubler, R. Chizzonite, C. Fargeas, and G. Delespesse, “Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes,” The Journal of Clinical Investigation, vol. 90, no. 1, pp. 262–266, 1992. View at Publisher · View at Google Scholar · View at PubMed
  23. J. C. Kips, G. J. Brusselle, G. F. Joos et al., “Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 153, no. 2, pp. 535–539, 1996. View at Google Scholar
  24. J. Schwarze, E. Hamelmann, G. Cieslewicz et al., “Local treatment with IL-12 is an effective inhibitor of airway hyperresponsiveness and lung eosinophilia after airway challenge in sensitized mice,” Journal of Allergy and Clinical Immunology, vol. 102, no. 1, pp. 86–93, 1998. View at Publisher · View at Google Scholar
  25. S. P. Hogan, P. S. Foster, X. Tan, and A. J. Ramsay, “Mucosal IL-12 gene delivery inhibits allergic airways disease and restores local antiviral immunity,” European Journal of Immunology, vol. 28, no. 2, pp. 413–423, 1998. View at Publisher · View at Google Scholar
  26. S. J. Till, J. N. Francis, K. Nouri-Aria, and S. R. Durham, “Mechanisms of immunotherapy,” Journal of Allergy and Clinical Immunology, vol. 113, no. 6, pp. 1025–1034, 2004. View at Publisher · View at Google Scholar · View at PubMed
  27. T. De Smedt, M. van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser, “Effect of interleukin-10 on dendritic cell maturation and function,” European Journal of Immunology, vol. 27, no. 5, pp. 1229–1235, 1997. View at Publisher · View at Google Scholar · View at PubMed
  28. P. Kaliński, C. M. U. Hilkens, E. A. Wierenga, and M. L. Kapsenberg, “T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal,” Immunology Today, vol. 20, no. 12, pp. 561–567, 1999. View at Publisher · View at Google Scholar
  29. A. Langenkamp, M. Messi, A. Lanzavecchia, and F. Sallusto, “Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells,” Nature Immunology, vol. 1, no. 4, pp. 311–316, 2000. View at Publisher · View at Google Scholar · View at PubMed
  30. A. Sarashina, S. Tatami, N. Yamamura, Y. Tsuda, and T. Igarashi, “Population pharmacokinetics of epinastine, a histamine H1 receptor antagonist, in adults and children,” British Journal of Clinical Pharmacology, vol. 59, no. 1, pp. 43–53, 2005. View at Publisher · View at Google Scholar · View at PubMed
  31. A. G. Castro, M. Neighbors, S. D. Hurst et al., “Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide,” Journal of Experimental Medicine, vol. 192, no. 10, pp. 1529–1534, 2000. View at Publisher · View at Google Scholar
  32. T. Hirano, “Interleukin 6 and its receptor: ten years later,” International Reviews of Immunology, vol. 16, no. 3-4, pp. 249–284, 1998. View at Publisher · View at Google Scholar · View at PubMed
  33. R. F. Mortensen, “Macrophages and acute-phase proteins,” Immunology Series, vol. 60, pp. 143–158, 1994. View at Google Scholar
  34. M. Krüger, W. Schrödl, A. Lindner, and R. Kunze, “C-reactive protein (CRP)—an acute-phase protein with importance in laboratory medicine in veterinary medicine,” Tierarztliche Praxis, vol. 23, no. 3, pp. 236–240, 1995. View at Google Scholar
  35. M. Berry, C. Brightling, I. Pavord, and A. Wardlaw, “TNF-α in asthma,” Current Opinion in Pharmacology, vol. 7, no. 3, pp. 279–282, 2007. View at Publisher · View at Google Scholar · View at PubMed
  36. S. Mukhopadhyay, J. R. Hoidal, and T. K. Mukherjee, “Role of TNFα in pulmonary pathophysiology,” Respiratory Research, vol. 7, article 125, pp. 1–9, 2006. View at Publisher · View at Google Scholar · View at PubMed
  37. T. Kogahara, K. Asano, K.-I. Kanai et al., “Inhibitory action of epinastine hydrochloride on the function of monocyte-derived dendritic cells in vitro,” Japanese Pharmacology and Therapeutics, vol. 36, no. 12, pp. 1105–1118, 2008. View at Google Scholar
  38. F. Marteau, D. Communi, J. Boeynaema, and N. S. Gonzalez, “Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells,” Journal of Leukocyte Biology, vol. 76, no. 4, pp. 796–803, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. L. G. Corral, P. A. J. Haslett, G. W. Muller et al., “Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α,” The Journal of Immunology, vol. 163, no. 1, pp. 380–386, 1999. View at Google Scholar
  40. H. Shiraishi, H. Yoshida, K. Saeki et al., “Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells,” International Immunology, vol. 20, no. 9, pp. 1219–1229, 2008. View at Publisher · View at Google Scholar · View at PubMed
  41. I. J. Elenkov, E. Webster, D. A. Papanicolaou, T. A. Fleisher, G. P. Chrousos, and R. L. Wilder, “Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors,” The Journal of Immunology, vol. 161, no. 5, pp. 2586–2593, 1998. View at Google Scholar
  42. A. Eigler, B. Siegmund, U. Emmerich, K. H. Baumann, G. Hartmann, and S. Endres, “Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production,” Journal of Leukocyte Biology, vol. 63, no. 1, pp. 101–107, 1998. View at Google Scholar
  43. P. A. Molyvdas, F. W. James, and N. Sperelakis, “Azelastine effects on electrical and mechanical activities of guinea pig papillary muscles,” European Journal of Pharmacology, vol. 164, no. 3, pp. 547–553, 1989. View at Publisher · View at Google Scholar
  44. T. Tokunou, T. Ichiki, K. Takeda et al., “Thrombin induces interleukin-6 expression through the cAMP response element in vascular smooth muscle cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 11, pp. 1759–1763, 2001. View at Publisher · View at Google Scholar
  45. Y. Shi and J. J. Pestka, “Mechanisms for suppression of interleuikin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice,” The Journal of Nutritional Biochemistry. On line (10.1016/j.jnutbio.2008.04.006). View at Publisher · View at Google Scholar · View at PubMed
  46. A. K. Lee, S. H. Sung, Y. C. Kim, and S. G. Kim, “Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-α and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C/EBP and AP-1 activation,” British Journal of Pharmacology, vol. 139, no. 1, pp. 11–20, 2003. View at Publisher · View at Google Scholar · View at PubMed
  47. S. J. Yeo, J. G. Yoon, S. C. Hong, and A. K. Yi, “CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: alterations in IL-1 receptor-associated kinase expression,” The Journal of Immunology, vol. 170, no. 2, pp. 1052–1061, 2003. View at Google Scholar
  48. H. Francis, S. Glaser, S. DeMorrow et al., “Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway,” American Journal of Physiology, vol. 295, no. 2, pp. C499–C513, 2008. View at Publisher · View at Google Scholar · View at PubMed